| Literature DB >> 20331368 |
Xiayuan Liang1, Brian Greffe, Bruce Cook, Roger Giller, Douglas K Graham, Amy N McGranahan, Michael Wang.
Abstract
Gray zone lymphomas are defined as lymphoid malignancies that cannot be reliably classified into a single distinct disease entity after all available morphologic, immunophenotypic, and molecular investigations have been performed. The 2008 World Health Organization Classification proposed 2 gray zone lesions: (1) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma and (2) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. These gray zone lesions are rare, especially in pediatric patients, and create a great challenge to both pathologists and oncologists because this differential diagnosis has direct implications for management strategies. In this manuscript, we report 2 cases of pediatric patients with gray zone lymphoma and review clinicopathologic features, treatment options, and outcomes of this uncommon tumor.Entities:
Mesh:
Year: 2010 PMID: 20331368 DOI: 10.2350/09-10-0724-CR.1
Source DB: PubMed Journal: Pediatr Dev Pathol ISSN: 1093-5266